N-[ 18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography
In Alzheimer's disease, cerebral cortical butyrylcholinesterase (BChE) activity is reported to be elevated. Our aim was to develop a novel 18F-labeled tracer for quantifying cerebral BChE activity by positron emission tomography. With in vitro screening of N-[ 14C]ethylpiperidin-3- and 4-ylmeth...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2004-04, Vol.14 (8), p.1927-1930 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In Alzheimer's disease, cerebral cortical butyrylcholinesterase (BChE) activity is reported to be elevated. Our aim was to develop a novel
18F-labeled tracer for quantifying cerebral BChE activity by positron emission tomography. With in vitro screening of
N-[
14C]ethylpiperidin-3- and 4-ylmethyl esters,
N-[
14C]ethylpiperidin-4-ylmethyl butyrate was selected as a lead for
18F-labeling, affording
N-[
18F]fluoroethylpiperidin-4-ylmethyl butyrate. The
18F-labeled butyrate showed the required properties for in vivo BChE measurement, that is, the lipophilic nature of the authentic ester, high specificity to BChE, a moderate hydrolysis rate, and the hydrophilic nature of the metabolite.
Graphic |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2004.01.080 |